Navigation Links
Crucial role for molecule in muscle development

Research led by the University of East Anglia has discovered the crucial role of a molecule in skeletal muscle development.

The finding could have implications in the future for maintenance of healthy muscle or muscle regeneration in certain diseases, for example cancer and neuromuscular conditions such as muscular dystrophy.

The complexity and significance of microRNA molecules has only recently been recognized and they have been implicated in many biological processes, including disease. Until now nothing was known about their role in the development of skeletal muscle, which is pivotal for movement and supports healthy ageing.

Published this week in the journal Proceedings of the National Academy of Sciences (PNAS), the study was carried out by researchers in the School of Biological Sciences at UEA and the Weizmann Institute of Science, in Rehovot, Israel.

They showed that a particular microRNA, called miR-206, is crucial for normal muscle development in the embryo. MiR-206 switches off a gene called Pax3, this in turn allows early stage muscle cells to become more specialised contractile cells needed for muscle to function. The researchers suggest that this regulation is also important in adult muscle stem cells, which differentiate in response to muscle injury or exercise.

Lead author Andrea Mnsterberg, professor in developmental biology at UEA, said: "Muscle is vital to our well being, but it can become fragile, for example as we age or through muscle-wasting diseases. Therefore understanding how muscle tissue develops and is maintained is important."

"Discovering how the Pax3 gene is regulated by miR-206 and controls other genes that lead to muscle differentiation is significant. If you control Pax3 you could control when cells become more specialised and take on their unique function. We suggest that what we have learnt about embryo development also applies to adult muscle."

Prof Mnsterberg added: "While not the focus of this study, in theory if we could enhance the function of microRNAs in the body we might in the future be able to promote the maintenance of healthy muscle or muscle regeneration in certain diseases."


Contact: Cat Bartman
University of East Anglia

Related biology news :

1. Tiny variation in 1 gene may have led to crucial changes in human brain
2. Parsley, celery carry crucial component for fight against breast cancer, MU researcher finds
3. Blocking crucial molecule could help treat multiple sclerosis, Jefferson neuroscientists say
4. Nailing down a crucial plant signaling system
5. Payment Default Risks Remain a Crucial Issue for Businesses Across Europe
6. Vitamin D crucial to activating immune defenses
7. For HIV-infected children, quality of caregiver relationship is crucial
8. Crucial differences found among Latino populations facing heart disease risks
9. Caffeic acid inhibits colitis in a mouse model -- is a drug-metabolizing gene crucial?
10. Simplicity is crucial to design optimization at nanoscale
11. In lung cancer, silencing one crucial gene disrupts normal functioning of genome
Post Your Comments:
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... Cell Applications, Inc. and StemoniX announced ... up to one billion human induced pluripotent stem ... These high-quality, consistent stem cells enable researchers to ... more time doing meaningful, relevant research. This achievement ... process that produces affordable, reliable HiPSC for life ...
Breaking Biology Technology: